TY - JOUR
T1 - The impact of Boric Acid tubes on quantitative urinary bacterial cultures in hospitalized patients
AU - Ben-David, Debby
AU - Cohen, Yael
AU - Zohar, Iris
AU - Maor, Yasmin
AU - Schwartz, Orna
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/8
Y1 - 2024/8
N2 - Introduction: The accuracy of urine culture results can be affected by pre-analytical factors such as transport delays and storage conditions. The objectives of this study were to analyze urine collection practices and assess the impact of introducing boric acid tubes for urine collection on quantitative urinary bacterial cultures of hospitalized patients in medical wards. Methods: A quasi-experimental pre-post study conducted in an acute care facility. In the pre-intervention phase (2020–2021), urine samples were transported without preservatives at room temperature. In 2022 (post-intervention), we transitioned to boric acid transport tubes, evaluating its effect on significant bacterial growth (≥ 105 CFU/ml). Bivariate and multivariate analyses identified predictors of culture positivity. Results: Throughout the duration of the study, a total of 12,660 urine cultures were analyzed. Date and time documentation was complete for 38.3% of specimens. Culture positivity was higher with longer processing times: positivity was 21.3% (220/1034) when specimens were processed within 4 h, 28.4% (955/3364) when processed in 4–24 h, and 32.9% (137/417) when processed after 24 h (p < 0.0001). For 4-24-hour processing, positivity decreased from 30.4% (704/2317) pre-intervention to 24.0% (251/1047) post-intervention (p < 0.001), with no significant changes in < 4 or ≥ 24-hour specimens. Stratified analysis by processing time revealed that the intervention was associated with reduced positivity only in cultures processed within 4–24 h (OR 0.80, 95% CI 0.67–0.94; p = 0.008). Conclusion: The introduction of boric acid transport tubes predominantly influenced cultures transported within a 4–24-hour window. This presents an opportunity to improve urine tract infection diagnostic practices in healthcare settings.
AB - Introduction: The accuracy of urine culture results can be affected by pre-analytical factors such as transport delays and storage conditions. The objectives of this study were to analyze urine collection practices and assess the impact of introducing boric acid tubes for urine collection on quantitative urinary bacterial cultures of hospitalized patients in medical wards. Methods: A quasi-experimental pre-post study conducted in an acute care facility. In the pre-intervention phase (2020–2021), urine samples were transported without preservatives at room temperature. In 2022 (post-intervention), we transitioned to boric acid transport tubes, evaluating its effect on significant bacterial growth (≥ 105 CFU/ml). Bivariate and multivariate analyses identified predictors of culture positivity. Results: Throughout the duration of the study, a total of 12,660 urine cultures were analyzed. Date and time documentation was complete for 38.3% of specimens. Culture positivity was higher with longer processing times: positivity was 21.3% (220/1034) when specimens were processed within 4 h, 28.4% (955/3364) when processed in 4–24 h, and 32.9% (137/417) when processed after 24 h (p < 0.0001). For 4-24-hour processing, positivity decreased from 30.4% (704/2317) pre-intervention to 24.0% (251/1047) post-intervention (p < 0.001), with no significant changes in < 4 or ≥ 24-hour specimens. Stratified analysis by processing time revealed that the intervention was associated with reduced positivity only in cultures processed within 4–24 h (OR 0.80, 95% CI 0.67–0.94; p = 0.008). Conclusion: The introduction of boric acid transport tubes predominantly influenced cultures transported within a 4–24-hour window. This presents an opportunity to improve urine tract infection diagnostic practices in healthcare settings.
KW - Boric acid
KW - Urine cultures
UR - http://www.scopus.com/inward/record.url?scp=85196829122&partnerID=8YFLogxK
U2 - 10.1007/s10096-024-04874-z
DO - 10.1007/s10096-024-04874-z
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 38916642
AN - SCOPUS:85196829122
SN - 0934-9723
VL - 43
SP - 1639
EP - 1644
JO - European Journal of Clinical Microbiology and Infectious Diseases
JF - European Journal of Clinical Microbiology and Infectious Diseases
IS - 8
ER -